ARCHIVES

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | March 20, 2009

Download PDF Visit The Full Archive

Related Articles

Reasons NIH Women Scientists Leave: Family Roles, Lower Confidence.

November 2, 2007

NCI Programs: Study Finds Bomb Tests Raised I-131 Exposure in 1950’s, 1960’s

August 22, 1997

The Walgreens Connection: ACS Calls On Drug Stores To Stop Tobacco Sales

April 18, 2014

Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer

July 11, 2014

Also in this 8-page issue: White House appoints Koch Industries executive David Koch to the National Cancer Advisory Board. He asks: “How can we make the NCI elephant dance like a ballerina?”

September 17, 2004

In Congress: Human Genome Project Ahead Of Schedule, Collins Assert

March 27, 1998